logoInnovations in Non-Invasive Stone Treatment

Each year, more than three million Americans see a physician for kidney stones and over 700,000 procedures are performed to break large kidney stones.
SonoMotion is developing non-invasive solutions for kidney stone disease with two breakthrough products:
  • Break WaveTM will fragment large kidney stones faster, safer and more effectively than existing options.
  • Stone ClearTM, which is currently in clinical trials, will help clear the resulting stone fragments within 15 minutes in an office setting and also without general anesthesia or x-ray radiation.
  • September 7th, 2015

    Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.

  • August 1st, 2015

    SonoMotion secures a $1.75M non-dilutive SBIR grant funding from the NIH for the development of Stone ClearTM

  • Jan 11th, 2015

    SonoMotion reaches agreement with the University of Washington for exclusive license to an extensive IP portfolio related to Break WaveTM and Stone ClearTM.

  • May 19th, 2015

    Positive First-In-Man Stone ClearTM clinical trial results presented at the American Urological Association (AUA) meeting in New Orleans.

  • October 24th, 2014

    SonoMotion brings onboard Dr. Oren Levy as its Chief Executive Officer and Chairman of the Board.

  1. Fragmentation of Urinary Calculi In Vitro by Burst Wave Lithotripsy

    Maxwell AD, Cunitz BW, Kreider W, Sapozhnikov O, Hsi RS, Harper JD, Bailey MR, Sorensen MD. J Urol. 2015 Jan;193(1):338-44

  2. First-in-human feasibility trial for ultrasonic propulsion of kidney stones

    Harper JD, Cunitz BW, Dunmire B, Lee FC, Sorensen MD, Hsi RS, Thiel J, Wessells H, Lingeman JE, Bailey MR

  3. Preclinical safety and effectiveness studies of ultrasonic propulsion of kidney stones

    Harper JD, Dunmire B, Wang YN, Simon JC, Liggitt D, Paun M, Cunitz BW, Starr F, Bailey MR, Penniston KL, Lee FC, Hsi RS, Sorensen MD. Urology. 2014 Aug;84(2):484-9

  4. Bursting through limitations of SWL

    Thoma C. Nat Rev Urol. 2014 Oct;11(10):540

  5. Focused ultrasound to displace renal calculi: threshold for tissue injury

    Wang YN, Simon JC, Cunitz BW, Starr FL, Paun M, Liggitt DH, Evan AP, McAteer JA, Liu Z, Dunmire B, Bailey MR. J Ther Ultrasound. 2014 Mar 31;2:5.

  6. Focused ultrasonic propulsion of kidney stones: review and update of preclinical technology

    Sorensen MD, Bailey MR, Hsi RS, Cunitz BW, Simon JC, Wang YN, Dunmire BL, Paun M, Starr F, Lu W, Evan AP, Harper JD. J Endourol. 2013 Oct;27(10):1183-6

  • Oren Levy, PhD

    Chief Executive Officer
    Dr. Oren Levy is an experienced medical device leader and entrepreneur with an outstanding record of achievement. Dr. Levy played a key role in the management and acquisition of Fluid Medical, an ultrasound based medical device startup, by Volcano Corporation (acquired by Philips). Dr. Levy has led and managed multi-disciplinary teams including disposable, hardware and software R&D and product marketing in both large-company and entrepreneurial environments. Dr. Levy integrates a personal background in science, operations and management consulting to introduce structure and rigor to a start-up environment. Most recently, Dr. Levy led Volcano Corporation’s Mountain View office with $3.4M annual budget supervising an eleven person team developing a percutaneous forward looking intra‐cardiac ultrasound imaging device. Dr. Levy received a PhD in Biophysics and a double BA degree in Physics and Astrophysics from UC Berkeley.

  • Doug Corl, PhD

    Chief Technology Officer
    Dr. Corl is a proven and recognized ultrasound expert with over 35 years of experience in developing and delivering commercial ultrasound-based medical devices. Dr. Corl has 38 issued patents and was either the CTO or Chief Scientist for the past 24 years at both early stage startups and large multinational ultrasound-based companies, including Volcano Corporation, Keimar, PharmaSonics and Cardiometrics. Dr. Corl received a PhD in Electrical Engineering from Stanford University and a BA and MS in Electrical Engineering from UC Irvine.

Dr. James Lingeman, MD
Indiana University
Professor of Urology and President of the Endourological Society
Dr. Mathew Sorensen, MD, MS
University of Washington and Puget Sound VA Hospital
Assistant Professor of Urology and Director of the Comprehensive Metabolic Stone Clinic
Dr. Sari Levine, MD
El Camino Hospital, Mountain View CA
Urologist and President at El Camino Urology

Michael Bailey, PhD
University of Washington, Seattle
Faculty in Mechanical Engineering and Urology,
Senior Principal Engineer at the Applied Physics Lab and Program Director of NIH Program Projecton Lithotripsy

Barbrina Dunmire, MS
University of Washington, Seattle
Sr. Biomedical Engineer at Applied Physics Lab
Bryan Cunitz, MS
University of Washington, Seattle
Sr. Electrical Engineer at the Applied Physics Lab
Adam Maxwell, PhD
University of Washington, Seattle
Acting Assistant Professor in Urology

Contact Us


SonoMotion Inc.

415 Grand Ave, Suite 302.,
South San Francisco, CA 94080


Dr. Oren Levy, CEO
Email: info@sonomotion.com